Discounted Cash Flow
Sanofi ADR
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $34.7b | $4.7b | $-5.0b | 13.6% | $3.66 |
| 2017 | $36.2b (4.3%) | $8.4b (79.1%) | $5.2b (204.3%) | 23.3% (71.7%) | $6.71 (83.3%) |
| 2018 | $35.7b (-1.5%) | $4.3b (-48.9%) | $4.4b (-14.8%) | 12.1% (-48.2%) | $3.45 (-48.6%) |
| 2019 | $37.6b (5.5%) | $2.8b (-34.8%) | $7.7b (74.0%) | 7.5% (-38.2%) | $2.24 (-35.1%) |
| 2020 | $37.4b (-0.7%) | $12.3b (338.8%) | $6.6b (-14.3%) | 33.0% (341.9%) | $9.82 (338.4%) |
| 2021 | $39.2b (4.8%) | $6.2b (-49.5%) | $10.1b (53.0%) | 15.9% (-51.8%) | $4.97 (-49.4%) |
| 2022 | $45.4b (15.9%) | $8.4b (34.5%) | $9.1b (-9.9%) | 18.4% (16.1%) | $6.69 (34.6%) |
| 2023 | $46.4b (2.3%) | $5.4b (-35.5%) | $8.7b (-5.1%) | 11.6% (-37.0%) | $4.31 (-35.6%) |
| 2024 | $44.3b (-4.6%) | $5.6b (3.0%) | $8.3b (-4.3%) | 12.6% (8.0%) | $4.44 (3.0%) |
| 2025 | $46.7b (5.5%) | $7.8b (40.5%) | $5.5b (-33.4%) | 16.7% (33.2%) | $6.40 (44.1%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.